NCT07492693 2026-03-25
Efficacy and Safety of Hetrombopag in Preventing Chemotherapy-induced Thrombocytopenia in Gastrointestinal Tumors
Changhai Hospital
Phase 2 Recruiting
Clinical Trials
1 trialsChemotherapy-induced Thrombocytopenia (CIT) in Patients With Gastrointestinal Tumors × hetrombopag × 90 days × Clear all